131 related articles for article (PubMed ID: 22052332)
1. Insulin-induced mTOR activity exhibits anti-hepatitis C virus activity.
Muraoka T; Ichikawa T; Taura N; Miyaaki H; Takeshita S; Akiyama M; Miuma S; Ozawa E; Isomoto H; Takeshima F; Nakao K
Mol Med Rep; 2012 Feb; 5(2):331-5. PubMed ID: 22052332
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway.
Matsumoto A; Ichikawa T; Nakao K; Miyaaki H; Hirano K; Fujimito M; Akiyama M; Miuma S; Ozawa E; Shibata H; Takeshita S; Yamasaki H; Ikeda M; Kato N; Eguchi K
J Gastroenterol; 2009; 44(8):856-63. PubMed ID: 19436942
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.
Huang H; Kang R; Wang J; Luo G; Yang W; Zhao Z
Autophagy; 2013 Feb; 9(2):175-95. PubMed ID: 23169238
[TBL] [Abstract][Full Text] [Related]
4. p21-activated kinase 1 is activated through the mammalian target of rapamycin/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells.
Ishida H; Li K; Yi M; Lemon SM
J Biol Chem; 2007 Apr; 282(16):11836-48. PubMed ID: 17255101
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin.
Kristof AS; Marks-Konczalik J; Billings E; Moss J
J Biol Chem; 2003 Sep; 278(36):33637-44. PubMed ID: 12807916
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.
Shao RX; Zhang L; Peng LF; Sun E; Chung WJ; Jang JY; Tsai WL; Hyppolite G; Chung RT
J Virol; 2010 Jun; 84(12):6060-9. PubMed ID: 20375166
[TBL] [Abstract][Full Text] [Related]
7. Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication.
Mannová P; Beretta L
J Virol; 2005 Jul; 79(14):8742-9. PubMed ID: 15994768
[TBL] [Abstract][Full Text] [Related]
8. Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.
Takeshita S; Ichikawa T; Taura N; Miyaaki H; Matsuzaki T; Otani M; Muraoka T; Akiyama M; Miuma S; Ozawa E; Ikeda M; Kato N; Isomoto H; Takeshima F; Nakao K
J Gastroenterol; 2012 Feb; 47(2):195-202. PubMed ID: 22038554
[TBL] [Abstract][Full Text] [Related]
9. Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
Liu WL; Yang HC; Hsu CS; Wang CC; Wang TS; Kao JH; Chen DS
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14799-14804. PubMed ID: 27930338
[TBL] [Abstract][Full Text] [Related]
10. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
11. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
Zhang L; Jilg N; Shao RX; Lin W; Fusco DN; Zhao H; Goto K; Peng LF; Chen WC; Chung RT
J Hepatol; 2011 Aug; 55(2):289-98. PubMed ID: 21147189
[TBL] [Abstract][Full Text] [Related]
12. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR.
Peng L; Liang D; Tong W; Li J; Yuan Z
J Biol Chem; 2010 Jul; 285(27):20870-81. PubMed ID: 20439463
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PI3K-Akt-mTOR signal pathway dismissed the stimulation of glucose on goose liver cell growth.
Wei S; Han C; He F; Song Q; Kang B; Liu H; Li L; Xu H; Zeng X
J Anim Physiol Anim Nutr (Berl); 2017 Oct; 101(5):e133-e143. PubMed ID: 27859698
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
16. Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin.
Pisonero-Vaquero S; García-Mediavilla MV; Jorquera F; Majano PL; Benet M; Jover R; González-Gallego J; Sánchez-Campos S
Lab Invest; 2014 Mar; 94(3):262-74. PubMed ID: 24492281
[TBL] [Abstract][Full Text] [Related]
17. LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway.
Chen Z; Yang L; Liu Y; Tang A; Li X; Zhang J; Yang Z
Mol Cell Biochem; 2014 Jan; 385(1-2):169-77. PubMed ID: 24072614
[TBL] [Abstract][Full Text] [Related]
18. VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway.
Villaume K; Blanc M; Gouysse G; Walter T; Couderc C; Nejjari M; Vercherat C; Cordier-Bussat M; Roche C; Scoazec JY
Neuroendocrinology; 2010; 91(3):268-78. PubMed ID: 20389030
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway.
Guo H; Zhou T; Jiang D; Cuconati A; Xiao GH; Block TM; Guo JT
J Virol; 2007 Sep; 81(18):10072-80. PubMed ID: 17609269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
